UK-based biotech company Oyster Therapeutics has raised $60 million in Series A funding, with participation from CE-Ventures, the corporate venture capital arm of UAE-based Crescent Enterprises. CE-Ventures' individual investment amount was not disclosed.
US-based venture capital firm 500 Global and Saudi Arabia's Sanabil Investments, a wholly owned subsidiary of the Public Investment Fund (PIF), have selected seven startups from 888 applications for the 12th cohort of the Sanabil Accelerator by 500 Global.
Former Redfin CEO Glenn Kelman has co-founded Sojourn, a stealth health care startup combining software, doctors and nurses, and an insurance company. He isn't talking yet, but public records led us to Sojourn and its plan to fix another screwed-up industry.
S. IPO services leader at PricewaterhouseCoopers, discussed the slowdown in IPO momentum, how public investors are evaluating AI companies, biotech’s resurgence and why SPACs are attracting renewed interest.